Patented Bone Conduction Transducer Technology
Our patented transducer converts sound into precise vibrations that stimulate the cochlea via the condyle, enabling a stable, hygienic, fully open‑ear listening experience.
DSP Processing
The microphone and DSP apply filtering, noise reduction, and compression to enhance speech and drive the bone conduction transducer. Clinically, bone conduction helps assess cochlear function, differentiate hearing loss types, and support patients who cannot use air conduction aids.
Who is a candidate
Bone conduction solutions are appropriate for patients with:
- Patients above 6 years old with Conductive or Mixed Hearing Loss. The pure tone average bone conduction hearing threshold (measured at 0.5, 1, 2, and 4kHz) should be ≤ 60 dB HL.
- Patients 18 years and older with Sensorineural Hearing Loss. The pure tone average bone conduction hearing threshold (measured at 0.5, 1, 2, and 4kHz) should be ≤ 60 dB HL.
A Simple, Intuitive Clinical Workflow
ShokzHear Professional Fitting gives audiologists an easy‑to‑use, integrated workflow for hearing evaluation and device configuration, making in‑clinic fitting faster and more intuitive.
Clinicians can use Audiogram Management to adjust air and bone conduction thresholds and view real time charts, with optional in‑situ testing for added accuracy.
Once the audiogram is entered, Initial Gain Setup automatically generates the starting gain.
In Personalized Adjustments, clinicians fine‑tune key parameters with realtime checks, and adjust two listening modes for quiet and noisy environments.
Clinical Evidence
Age and Hearing Loss Type
The 55 enrolled patients had a mean age of 55.0 ± 17.2 years, with mixed hearing loss as the predominant type.
Sound-Field Thresholds, Word Recognition, and Speech Recognition
The 4FA sound-field threshold, monosyllabic word recognition, and speech recognition threshold all showed significant improvements after 14 ± 2 days of device use (P < 0.01).
Sound-Field Thresholds, Word Recognition, and Speech Recognition
Patients with conductive, mixed, and sensorineural hearing loss all showed significant improvements in hearing performance after device use (P < 0.01).
Device Use, Perceived Benefit, Satisfaction, Activity, Participation, and Quality of Life
Patient-reported outcomes were consistently favorable, with average IOI-HA scores ≥4.0 across all hearing loss groups.
For Professionals
Interested in OpenHear for Your Practice?
Contact us to learn more about clinical indications, fitting workflow, and professional support.